Drug Trial Radar · NCT06966401
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
850
Planned (sponsor's estimate)
Start
Apr 16, 2025
Primary completion
May 2029
Study completion May 2030
Sponsor
- Lead sponsor
- Neurocrine BiosciencesNeurocrine Biosciences (NBIX)
- Sponsor type
- Industry
- First posted
- May 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.
Conditions
- Major Depressive Disorder
Interventions
NBI-1065845Drug
NBI-1065845 tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Treatment-emergent Adverse Events (TEAEs)Time frame: Baseline through Week 52
Locations
120 sites in 23 countries. Site status is shown where the registry gives one.
Neurocrine Clinical Site
Huntsville, Alabama · Recruiting
Neurocrine Clinical Site
Bryant, Arkansas · Recruiting
Neurocrine Clinical Site
Little Rock, Arkansas · Recruiting
Neurocrine Clinical Site
Chino, California · Recruiting
Neurocrine Clinical Site
Glendale, California · Recruiting
Neurocrine Clinical Site
Irvine, California · Recruiting
Neurocrine Clinical Site
Los Angeles, California · Recruiting
Neurocrine Clinical Site
Oceanside, California · Recruiting
Neurocrine Clinical Site
Orange, California · Recruiting
Neurocrine Clinical Site
Pico Rivera, California · Recruiting
Neurocrine Clinical Site
San Diego, California · Recruiting
Neurocrine Clinical Site
San Francisco, California · Active not recruiting
Neurocrine Clinical Site
San Jose, California · Recruiting
Neurocrine Clinical Site
Upland, California · Terminated
Neurocrine Clinical Site
Cromwell, Connecticut · Recruiting
Neurocrine Clinical Site
Farmington, Connecticut · Recruiting
Neurocrine Clinical Site
Hollywood, Florida · Recruiting
Neurocrine Clinical Site
Maitland, Florida · Recruiting
Neurocrine Clinical Site
Maitland, Florida · Recruiting
Neurocrine Clinical Site
Miami, Florida · Recruiting
Neurocrine Clinical Site
Miami Gardens, Florida · Recruiting
Neurocrine Clinical Site
Orlando, Florida · Withdrawn
Neurocrine Clinical Site
Palm Bay, Florida · Recruiting
Neurocrine Clinical Site
Tampa, Florida · Recruiting
Neurocrine Clinical Site
Tampa, Florida · Recruiting
Neurocrine Clinical Site
Tampa, Florida · Recruiting
Neurocrine Clinical Site
Atlanta, Georgia · Recruiting
Neurocrine Clinical Site
Gaithersburg, Maryland · Recruiting
Neurocrine Clinical Site
Boston, Massachusetts · Recruiting
Neurocrine Clinical Site
Watertown, Massachusetts · Recruiting
Neurocrine Clinical Site
O'Fallon, Missouri · Recruiting
Neurocrine Clinical Site
Saint Charles, Missouri · Recruiting
Neurocrine Clinical Site
Cedarhurst, New York · Recruiting
Neurocrine Clinical Site
Mount Kisco, New York · Recruiting
Neurocrine Clinical Site
New York, New York · Recruiting
Neurocrine Clinical Site
New York, New York · Recruiting
Neurocrine Clinical Site
The Bronx, New York · Recruiting
Neurocrine Clinical Site
Avon Lake, Ohio · Recruiting
Neurocrine Clinical Site
Edmond, Oklahoma · Recruiting
Neurocrine Clinical Site
Oklahoma City, Oklahoma · Withdrawn
Showing 40 of 120 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.